Literature DB >> 8989954

Long-term effects of Ménière's disease on hearing and quality of life.

S E Kinney1, S A Sandridge, C W Newman.   

Abstract

OBJECTIVE: To evaluate long-term hearing results and quality of life in patients with Ménière's disease. STUDY
DESIGN: Detailed audiometric evaluation and disease-specific as well as global health quality evaluation of patients with Ménière's disease.
SETTING: Ambulatory evaluation was conducted in a large multispecialty clinic. PATIENTS: Ménière's disease in only one ear, were at least 1 year posttreatment, were < 65 years of age, had no neurologic or psychologic disorders, and lived within driving distance of the ambulatory clinic. MAIN OUTCOME MEASURES: Audiometry, the Hearing Handicap Inventory, Dizziness Handicap Inventory, Tinnitus Handicap Inventory, and SF-36 Health Survey.
RESULTS: No statistically significant differences in long-term hearing results were detected from natural history in medically or surgically treated patients with Ménière's disease. A significant disease-specific symptom handicap was detected. The global health handicap was greater for emotional disability than for physical disability.
CONCLUSIONS: Medical and surgical treatment does not significantly influence hearing results in Ménière's disease. Patients with Ménière's disease have a greater emotional disability than a physical disability.

Entities:  

Mesh:

Year:  1997        PMID: 8989954

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  10 in total

1.  Treatment of Menière's Disease.

Authors:  Jeffrey D Sharon; Carolina Trevino; Michael C Schubert; John P Carey
Journal:  Curr Treat Options Neurol       Date:  2015-04       Impact factor: 3.598

2.  Unilateral visual impairment and health related quality of life: the Blue Mountains Eye Study.

Authors:  E-M Chia; P Mitchell; E Rochtchina; S Foran; J J Wang
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

3.  Expression of circadian clock genes in leukocytes of patients with Meniere's disease.

Authors:  Chao-Hui Yang; Chung-Feng Hwang; Nai-Wen Tsai; Ming-Yu Yang
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-02-18

Review 4.  The Influence of Psychological Factors in Meniere's Disease.

Authors:  Ft Orji
Journal:  Ann Med Health Sci Res       Date:  2014-01

5.  Effects and tolerability of betahistine in patients with vestibular vertigo: results from the Romanian contingent of the OSVaLD study.

Authors:  Ovidiu Băjenaru; Adina Maria Roceanu; Silviu Albu; Viorel Zainea; Alexandru Pascu; Mădălina Gabriela Georgescu; Sebastian Cozma; Luigi Mărceanu; Dafin Fior Mureşanu
Journal:  Int J Gen Med       Date:  2014-12-04

6.  Atmospheric Pressure and Onset of Episodes of Menière's Disease - A Repeated Measures Study.

Authors:  Robert Gürkov; Ralf Strobl; Nina Heinlin; Eike Krause; Bernhard Olzowy; Christina Koppe; Eva Grill
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

7.  Betahistine in the treatment of Ménière's disease.

Authors:  Michel Lacour; Paul H van de Heyning; Miroslav Novotny; Brahim Tighilet
Journal:  Neuropsychiatr Dis Treat       Date:  2007-08       Impact factor: 2.570

8.  Impact evaluation and association with EuroQol 5D health-related utility values in Ménière's disease.

Authors:  Ilmari Pyykkő; Vinaya Manchaiah; Hilla Levo; Erna Kentala
Journal:  Springerplus       Date:  2015-11-24

9.  Hearing function after betahistine therapy in patients with Ménière's disease.

Authors:  Seyed Javad Seyed Tootoonchi; Samad Ghiasi; Parvaneh Shadara; Simin Mirakhor Samani; Daniel Fadaei Fouladi
Journal:  Braz J Otorhinolaryngol       Date:  2015-12-18

10.  The outcome of patients with Ménières disease.

Authors:  Adriana Gonzaga Chaves; Letícia Boari; Mário Sérgio Lei Munhoz
Journal:  Braz J Otorhinolaryngol       Date:  2007 May-Jun
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.